NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Monitoring oxycodone therapy
Routine drug monitoring is not indicated in all patients. Because drug diversion (use of prescription drugs for recreational purposes) is a possibility, compliance monitoring is indicated in patients being treated for chronic pain requiring high doses (>40 mg twice a day)
Gas Chromatography-Mass Spectrometry Using Selected Ion Monitoring (GC-MS SIM)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Oxycodone (Oxycontin, Percodan)